326
Participants
Start Date
October 31, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
November 30, 2012
ACT-128800
ACT-128800 (Dose 1 or Dose 2) or matching placebo administered orally once daily
Placebo
ACT-128800 (Dose 1 or Dose 2) or matching placebo administered orally once daily
Clinical Investigative Site 3101, Lausanne
Clinical Investigative Site 2002, Budapest
Clinical Investigative Site 1007, Vienna
Clinical Investigative Site 1103, Brussels
Clinical Investigative Site 1202, Sofia
Clinical Investigative Site 1201, Sofia
Clinical Investigative Site 1203, Sofia
Clinical Investigative Site 1502, Copenhagen
Clinical Investigative Site 1102, Edegem
Clinical Investigative Site 1004, Sankt Pölten
Clinical Investigative Site 2006, Miskolc
Clinical Investigative Site 1101, Liège
Clinical Investigative Site 1504, Roskilde
Clinical Investigative Site 1204, Plovdiv
Clinical Investigative Site 2001, Debrecen
Clinical Investigative Site 1205, Pleven
Clinical Investigative Site 1206, Stara Zagora
Clinical Investigative Site 2003, Szeged
Clinical Investigative Site 1006, Feldkirch
Clinical Investigative Site 2005, Pécs
Clinical Investigative Site 1002, Graz
Clinical Investigative Site 3103, Zurich
Clinical Investigative Site 2004, Veszprém
Clinical Investigative Site 1401, Prague
Clinical Investigative Site 2317, Genova
Clinical Investigative Site 3001, Stockholm
Clinical Investigative Site 2303, Bergamo
Clinical Investigative Site 2902, Madrid
Clinical Investigative Site 2904, Madrid
Clinical Investigative Site 3512, Poltava
Clinical Investigative Site 2307, Bologna
Clinical Investigative Site 1702, Saint-Etienne
Clinical Investigative Site 1402, Hradec Králové
Clinical Investigative Site 1406, Pardubice
Clinical Investigative Site 2310, Pisa
Clinical Investigative Site 2315, Ancona
Clinical Investigative Site 2309, L’Aquila
Clinical Investigative Site 3514, Zaporizhia
Clinical Investigative Site 1705, Pierre-Bénite
Clinical Investigative Site 1405, Nový Jičín
Clinical Investigative Site 1707, Paris
Clinical Investigative Site 1710, Paris
Clinical Investigative Site 1704, Bordeaux
Clinical Investigative Site 1703, Poitiers
Clinical Investigative Site 3006, Umeå
Clinical Investigative Site 2708, Trnava
Clinical Investigative Site 2704, Banská Bystrica
Clinical Investigative Site 2602, Timișoara
Clinical Investigative Site 3410, Krasnodar
Clinical Investigative Site 2604, Cluj-Napoca
Clinical Investigative Site 2606, Oradea
Clinical Investigative Site 2605, Târgu Mureş
Clinical Investigative Site 2607, Sibiu
Clinical Investigative Site 2603, Iași
Clinical Investigative Site 1001, Vienna
Clinical Investigative Site 1701, Nice
Clinical Investigative Site 2304, Roma
Clinical Investigative Site 2316, Rome
Clinical Investigative Site 3801, Vilnius
Clinical Investigative Site 2907, Las Palmas de Gran Canaria
Clinical Investigative Site 2608, Bucharest
Clinical Investigative Site 2601, Bucharest
Clinical Investigative Site 2705, Kosice-Saca
Clinical Investigative Site 2701, Košice
Clinical Investigative Site 2901, Barcelona
Clinical Investigative Site 3306, Dundee
Clinical Investigative Site 3304, London
Lead Sponsor
Actelion
INDUSTRY